What is Newsflash.Extra?

* A secure subscription-only service, used daily by many multinationals, that gives you exclusive access to the Newsflash.Extra web pages

* The best way to keep you and your company informed about the world of OTC but without information overload

* A concise, accessible and easy to use service which provides vital background information and essential insight into consumer healthcare, plus a host of other features

What does Newsflash.Extra offer?

The opportunity to download ready-prepared background briefings, profiles and analysis or to search for specific key facts.All briefings are available in PDF format for easyon-screen reading or download, with in‑built links to relevant news stories and related features.

Newsflash.Extra has unique features available only to subscribers:

• The News in Context Every Friday OTC.newsflash covers 20-30 of the most important news stories and e-mails them direct to your desk. Newsflash.Extra subscribers can also see relevant market data and other background information, presented in graphics and easy access text, via a single mouse click

• Breaking News Really big news stories are e-mailed direct, as they happen, but only to Newsflash.Extra subscribers. Background details and implications are available on-line the same day, to help you analyse developments from your own company’s perspective

• Searchable Archive Enter one or two key words and pull up all references in OTC.newsflash for the past three years (and building)

• Global Review and Quarterly Trends – unique insight authored by Nicholas Hall

• Industry Hot Topics and Special News Briefings The background behind the latest M&A deals, Advisory OTCs, German dereimbursement, Japan's potential mass market, US battles over pseudoephedrine cold remedies, to give just a few examples. See key facts and background data, including an edited-down timeline of developments and implications

• The Top 25 OTC companies Rolling reviews of the leading OTC players, kept fully up to date

• M&A Register A complete list of all major deals struck in the OTC industry back to 1996, updated weekly with the most recent deals

How can I find out more?

Contact Filomena Pead (Filomena@NicholasHall.com; +44 (0)1702 220232) to discuss subscription details and to arrange a free trial for key executives.